Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors
Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Jul 3, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying an online Tai Chi program designed to help cancer survivors quit smoking. Tai Chi is a gentle exercise that involves slow movements, controlled breathing, and a calm mind. It’s a great option for people who may not want to use medications or other treatments to stop smoking. The program, called WaQi, lasts for 8 weeks and will take place through Zoom so participants can join from home.
To be eligible for this study, you need to be a cancer survivor aged 21 or older, speak and read English, and have smoked tobacco in the last 30 days with a strong interest in quitting. Participants will need access to a smartphone or tablet and be willing to use a free app and attend online sessions. If you’ve practiced Tai Chi regularly in the past six months or are a non-smoker, this study may not be for you. This trial offers a supportive way to explore smoking cessation while engaging in a gentle form of exercise, which could be beneficial for your overall health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer survivor (i.e., have had a cancer diagnosis)
- • Age 21 years and older
- • English speaking/reading
- • Report smoking tobacco in the past 30 days
- • Report at least moderate interest in quitting smoking (\>= 3 on a Likert type scale with 5 being very extremely interested)
- • Can participate in Zoom calls for orientation and intervention
- • Have access to a smartphone or tablet
- • Willing to download a free application (app)
- • Can commit to the 8-weeks intervention (WaQi program)
- • Are not currently or have not regularly practiced Tai Chi in the last 6 months
- • Willing to blow into a device (for carbon monoxide measurements)
- Exclusion Criteria:
- • Non-cancer survivors
- • Patients under 21 years old
- • Non-English speaking/reading
- • Non-smokers in the past 30 days
- • Report lower than moderate interest in quitting smoking (\< 3 on a Likert type scale with 5 being very extremely interested)
- • Cannot to participate Zoom calls for orientation and intervention
- • No access to a smartphone or tablet
- • Not willing to download a free app
- • Cannot commit to the intervention
- • Has practiced Tai Chi regularly in the last 6 months
- • Not willing to blow into a device
- • Eligible, but sampling quotas full
About Ohio State University Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Ce Shang, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported